Smith, Madeleine J.
Pellegrini, Michael
Major, Brendan
Graco, Marnie
Porter, Stephanie
Kramer, Sharon
Sewell, Katherine
Salberg, Sabrina
Chen, Zhibin
Mychasiuk, Richelle
Lannin, Natasha A.
Funding for this research was provided by:
National Health and Medical Research Council (GNT1156444, GNT117365)
National Heart Foundation of Australia (GNT 106762)
Article History
Received: 2 August 2023
Accepted: 10 May 2024
First Online: 28 May 2024
Declarations
:
: Written informed consent was obtained from all subjects involved in this study. The study was conducted in accordance with the Declaration of Helsinki and the protocol was approved by the Alfred Health Human Research Ethics Committee (Project ID: 660/21).
: Not applicable.
: The authors declare no competing interests.
: EQ-5D-5 L = EuroQol-5D-5 L; FIM = Functional Independence Measure; MCA = middle cerebral artery; NIHSS = National Institutes of Health Stroke Scale.
: BDNF = Brain derived neurotrophic factor; CRP = C-reactive protein; FSS = Fatigue Severity Scale; IL1-β = Interleukin 1 beta, MTNR1A = Melatonin receptor 1a, MTNR1B = Melatonin receptor 1b; NIHSS = National Institutes of Health Stroke Scale; NR3C1 = Glucocorticoid receptor; TNF- α = Tumour necrosis factor alpha; VAFS = Visual Analogue Fatigue Scale.